期刊文献+

丙型病毒性肝炎患者流行及治疗现状调查 被引量:4

Epidemiologic and therapeutic status study of patients with hepatitis C
原文传递
导出
摘要 目的探讨丙型病毒性肝炎患者的感染途径、从感染到发现病情所需时间、从发现病情到治疗所需时问。方法对2004年3月至2010年7月到广州市第八人民医院就诊的216例慢性丙型病毒性肝炎患者的感染途径、发现病情年限和治疗年限进行回顾性分析。结果72.22%的患者患有输血后丙肝(PTHC),27.78%的患者患有散发性丙肝(SHC)。32.61%的患者感染丙肝病毒15~20年后才发现病情,3.26%的患者20年以上才发现病情,33.80%的患者发现病情5年以上给予抗病毒治疗,17.13%的患者发现病情1O~15年后才给予治疗。结论大多数患者通过输血或血制品感染上丙肝,大多数患者感染丙肝病毒15年以上才发现病情,有将近一半的患者发现病情5年以上进行治疗,相当一部分发现病情10余年后才进行治疗。 Objective To investigate the different infective mode, the time from be infectived to be diagnosed and the time from be diagnosed to be treated of patients with hepatitis C. Methods The different infective mode, the time from be infectived to be diagnosed and the time from be diagnosed to he treated of 216 patients with hepatitis C from march 2004 to march 2009 were retrospectively analyzed. Results 72.22 percents patients suffered from post transfusion hepatitis C (PTHC) and 27.78 percents patients suffered from sporadic hepatitisC (SHC). 32.61 percents patients were diagnosed after be infectived 15-20 years later. 3.26 percents patients were diagnosed after be infectived more than 20 years later. 33.80 percents patients were treated after be diagnosed more than 5 years later. 17. 13 percents patients were treated after be diagnosed 10-15 years later. Conclusion Most patients were infeetived with hepatitis C by transfusing blood or blood products. Most patients were diagnosed after be infectived more than 15 years later. Almost half of patients were treated after be diagnosed more than 5 years later, and a significant portion of percents patients were treated after be diagnosed more than 10 years later.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 北大核心 2011年第2期135-136,共2页 Chinese Journal of Experimental and Clinical Virology
基金 国家“十一五”科技重大专项课题:HIV合并HCV感染人群抗病毒治疗研究(编号:2008ZXl000l-008)
关键词 肝炎 丙型 感染 流行病学因素 Hepatitis C Infection Epidemiologie foctors
  • 相关文献

参考文献5

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2Wise M,Bialek S,Finelli L,et al.Changing trends in hepatitis C-related mortality in the United States,1995-2004.Hepatology,2008,47:1128-1135.
  • 3Davis GL,Albright JE,Cook SF,et al.Projecting future complications of chronic hepatitis C ia the United States.Liver Transpl,2003,9:331-338.
  • 4施小明,马家奇,王丽萍,张春曦,郭青,戚晓鹏,郭岩,杨功焕.2005年全国医疗机构法定传染病漏报情况调查分析[J].疾病监测,2006,21(9):493-496. 被引量:128
  • 5Foster GR.Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus.Expert Opin Pharmacother,2003,4:685-691.

二级参考文献21

  • 1马家奇,王丽萍,戚晓鹏,张春曦,郭青,葛辉,郭岩.2004年法定传染病报告信息质量分析[J].疾病监测,2005,20(5):264-266. 被引量:159
  • 2陆运龙,杨成志,刘义威.玉林市2004年法定传染病漏报情况及原因分析[J].疾病控制杂志,2005,9(6):528-528. 被引量:14
  • 3刘立,高贵军,刘继敏,邓祖昆,董辉.河北省法定传染病疫情网络直报前后报告情况比较[J].实用预防医学,2005,12(5):1124-1125. 被引量:20
  • 4李琳,单爱兰,高璐,陈静,吕杰,刘辉,何海艳.天津市2004年医疗机构传染病报告质量评估[J].疾病监测,2005,20(11):587-589. 被引量:21
  • 5Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 6Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 7Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 8Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 9Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 10Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.

共引文献860

同被引文献29

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部